Cardio Diagnostics Holdings Inc. Common stock Stock Prediction
AI-powered sentiment analysis and prediction trends for CDIO, updated each market day.
CDIO AI Sentiment
AI sees no strong directional signal for Cardio Diagnostics Holdings Inc. Common stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
Sector
Exchange
Market Cap
$5,356,638
Cap Tier
Employees
17
Headquarters
CHICAGO, IL
Listed Since
Oct. 26, 2022
Website
CDIO Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CDIO Volatility
Cardio Diagnostics Holdings Inc. Common stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
